Abandonment of prescribed buprenorphine for opioid use disorder, 2020-2024

About the Study : This cohort study analyzes factors associated with abandonment of newly prescribed buprenorphine among US adults from 2020 to 2024.

Corresponding Author : Xinyi Jiang, PhD, MS, Division of Overdose Prevention, Centers for Disease Control and Prevention, 4770 Buford Hwy, Atlanta, GA 30341 ( qkz4@cdc.gov ).

10.1001/jamanetworkopen.2026.27142

To access the embargoed study: Visit our JAMA Network Media Center at this link https://media.jamanetwork.com/

Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2026.27142?guestAccessKey=1db66b39-91d4-4a88-b5b1-334a938dd52d&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=080426

Editor's Note : Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

JAMA Network Open